Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.68

-2.4%

Dec 12 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: former_pgs who wrote (14183)	11/17/2004 4:23:31 PM
From: Biomaven	Read Replies (2) of 52153

protracted Thalidomide approval process for myeloma I haven't owned CELG in quite a while, although I did very well with it for a couple of years. So I've never understood the delay in FDA approval for Thalomid for myeloma given the clear efficacy and the fact that it is so widely used. Can you explain what the delay has been? Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next